Showing results (1681-1690 of 1,866) with videos related to
Sort By:
Pageof 187
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2017
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic LeukemiaJingmei Hsu, Andrew Artz, Sebastian A Mayer, et al.The Journal of Infectious Diseases|May 16, 2022
Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 OutpatientsNeil R Aggarwal, Laurel E Beaty, Tellen D Bennett, et al.Transplantation|October 15, 2024
Functional Natural Killer-cell Genetics and Microvascular Inflammation After Kidney Transplantation: An Observational Cohort StudyMatthias Diebold, Hannes Vietzen, Martina Schatzl, et al.BMC Infectious Diseases|November 7, 2022
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatientsDavid J Douin, Adane F Wogu, Laurel E Beaty, et al.Trials|April 9, 2022
Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trialKatharina A Mayer, Klemens Budde, Philip F Halloran, et al.Journal of Endodontics|August 18, 2020
Analysis of Active Bacteria Persisting after Chemomechanical Procedures: An RNA- and DNA-based Molecular StudyLaura C L Nardello, Bruna G Vilela, Fernanda S Fernandes, et al.Journal of the Neurological Sciences|July 1, 2023
Significant increase in mortality and risk of acute ischemic stroke in infective endocarditis patients with subarachnoid hemorrhage secondary to mycotic aneurysmsTolga Sursal, Kevin Clare, Eric Feldstein, et al.Future Oncology (London, England)|February 28, 2025
CAMBRIA-1 & CAMBRIA-2 phase III trials: camizestrant versus standard endocrine therapy in ER+/HER2- early breast cancerErika P Hamilton, Sibylle Loibl, Thomas Bachelot, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2018
Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103)Kathy D Miller, Anne O'Neill, William Gradishar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2026
CSF1R Inhibition with Chemotherapy Relieves Systemic Immune Suppression in Patients with Metastatic Triple-Negative Breast Cancer and Boosts anti-PD-1 Efficacy in Transgenic Mammary TumorsAmanda Poissonnier, Hope S Rugo, Wesley Horton, et al.Pageof 187